Results 141 to 150 of about 1,809 (187)

Hémovigilance et incidents transfusionnels chez les receveurs : Fréquence, étiologies et propositions d’amélioration

La Tunisie medicale
 Introduction-Aim : Blood transfusion can lead to transfusion-related incidents with varying degrees of severity. The aim of this study is to determine the frequency and causes of transfusion-related incidents, as well as to propose corrective actions to
Houda Romdhane, Imen Jarray, Zeineb Benlamine, Farah Yacoub, Neila Boukadida, Batoul Houissa   +5 more
semanticscholar   +1 more source

Don't Ask Don't Tell - The Status, Barriers, and Opportunities for Hospital Transfusion Committees (HTCs) in Rivers State, Nigeria: Mixed Methods Research on Hemovigilance.

Nigerian Journal of Clinical Practice
BACKGROUND Blood and blood products are life-saving interventions, preventing millions of deaths annually. However, they present ethical and clinical risks from transfusing wrong blood, near misses, and infectious and immunologic risks, which effective ...
A. Oreh, V. Agala, J. Darlington-Woke, F. Funso-Adebayo, J. Fapohunda, I. Mgbachi, T. Bozegha, F. Biyama, A. Oyetunde, B. Ogbonda, S. Owusu-Ofori, M. Postma, T. Nwagha, M. van Hulst   +13 more
semanticscholar   +1 more source

Transfusion‐related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module — United States, 2013–2018

Transfusion, 2021
Despite current blood safety measures, transfusion recipients can experience transfusion‐related adverse reactions. Monitoring these reactions can aid in understanding the effectiveness of current transfusion safety measures.
Ian Kracalik, Sanjida J. Mowla, S. Basavaraju, M. Sapiano   +3 more
semanticscholar   +1 more source

A study to assess and grade the donor adverse events using the severity grading tool of hemovigilance program of India

Asian Journal of Transfusion Science
Donor vigilance is the monitoring of donor adverse events (DAEs) to improve donor safety and the quality of the blood donation process. This study aimed to grade and assess DAEs using a new severity grading tool (SGT) by the Hemovigilance Programme
Punkesh Patel, Vinu Rajendran, A. Nair, Debasish Gupta   +3 more
semanticscholar   +1 more source

Hemovigilance in developing countries

Biologicals, 2010
Hemovigilance like quality systems and audits has become an integral part of the Blood Transfusion Service (BTS) in the developed world and has contributed greatly to the development of the blood service. However developing countries are still grappling with donor recruitment and efforts towards sufficiency and safety of the blood supply.
openaire   +2 more sources

Knowledge, attitude, and practice studies on hemovigilance in India: A critical appraisal

Transfusion Medicine
Hemovigilance is essential for monitoring, analysing, and preventing adverse transfusion reactions. Hemovigilance Programme of India (HvPI), launched in 2012, aims to improve transfusion safety.
Radheshyam Meher, Aparna Krishna, G. Patidar   +2 more
semanticscholar   +1 more source

Hemovigilance in Honduras

ISBT Science Series, 2012
Abstract: The Honduras Red Cross Blood Program has worked actively to implement a hemovigilance process which gathers information regarding the donors and the donation process as well as serious untoward effects in transfusion recipients. This review will go over the different epidemiological and statistical indicators that are used routinely to follow
openaire   +1 more source

Transfusion and Hemovigilance in Pediatrics

Pediatric Clinics of North America, 2013
Hemovigilance is an essential part of the transfusion process and is defined as surveillance procedures covering the whole transfusion chain, from collection of blood and its components, intended to collect and assess information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products and to prevent their ...
openaire   +2 more sources

Hemovigilance: Clinical Tolerance of Solvent‐Detergent Treated Plasma

Vox Sanguinis, 1998
AbstractObjective: This study was conducted to assess retrospectively the clinical tolerance of SD treated plasma and to compare it to other labile blood products (red blood cell and platelet concentrates). Method: Adverse events (AEs) related to the use of blood products at the Blood Transfusion Center (BTC) are routinely collected through a ...
Baudoux, Etienne, Margraff, U., Coenen, Alain, Jacobs, X., Deboutez, Martine, Lungu, C., Sondag-Thull, D.   +6 more
openaire   +2 more sources

Hemovigilance and artificial intelligence: A way forward

Transfusion Clinique et Biologique
Radheshyam Meher
openaire   +3 more sources